Asahi Kasei Pharma Corporation, Open Innovation platform is inviting proposals for its collaborative research program in drug discovery. The program aims to create innovative new drugs to match the company philosophy," contribute to life and living for people around the world". Realising this goal requires the combined power of many researchers, both internal and external to the company, providing innovation through the integration of their knowledge.
Asahi Kasei Pharma Corporation is a Japanese pharmaceutical company ranked in the top 20 in the Japanese pharmaceutical market. Since 2016, when it launched open innovation initiatives, and is devoted to strengthening and enhancing global licensing and alliance-building activities.
Research Topics Sought:
Submitting proposal period: Starts on January 7 14:00 (JST)
Deadline: February 25, 2021 17:00 (JST)
Submissions after deadline will not be accepted.
Further information on Asahi Kasei Pharma Corporation and on LinkedIn
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026
